Autosomal Dominant Polycystic Kidney Disease (ADPKD) Panel
Use
This test is intended for individuals with a clinical or suspected diagnosis of ADPKD and individuals or fetuses with very early onset PKD that mimics ARPKD. It is also useful for individuals with a family history of ADPKD who are being evaluated as potential kidney donors and individuals with atypical presentation and no family history of ADPKD.
Special Instructions
Ensure to use the correct specimen type according to the platform being used, either Exome or Genome. This test is not FDA approved but follows CLIA and CAP regulations. Turnaround time depends on the submission of all required information and specimens.
Limitations
The test is not FDA cleared or approved and interpretation relies heavily on the quality and completeness of clinical information provided alongside the test requisition.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
7-16 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Refer to standard collection methods for Exome Platform.